Wr. Wu et al., Immunosuppressive effects of dihydroetorphine, a potent narcotic analgesic, in dihydroetorphine-dependent mice, EUR J PHARM, 366(2-3), 1999, pp. 261-269
The immunomodulatory effects of dihydroetorphine were systematically invest
igated in subchronically treated mice. In a dose-dependent fashion, dihydro
etorphine (total doses at 444.5, 889 and 1778 mu g/kg) lowered the increase
of body weight, decreased the weight of the spleen and thymus, weakened th
e delayed-type hypersensitivity, reduced the generation of antibody-forming
cells, inhibited splenic lymphocyte proliferation induced by concanavalin
A and lipopolysaccharide, suppressed the production of interleukin-2 in the
supernatant of splenocytes induced by concanavalin A, and depleted the rat
io of CD4(+) and CD8(+) subpopulations. Moreover, the physical dependence o
n dihydroetorphine was also evaluated to confirm that the immunosuppression
was concomitant with the addiction to thr drug. These results demonstrate
that subchronic treatment with dihydroetorphine dose dependently suppresses
both humoral and cell-mediated immune function, and that the immunosuppres
sive effects of dihydroetorphine are much more potent than those of morphin
e. (C) 1999 Elsevier Science B.V. All rights reserved.